Trevi Therapeutics Inc.

4.26
-0.26 (-5.75%)
At close: Mar 03, 2025, 3:59 PM
4.35
2.11%
After-hours: Mar 03, 2025, 07:29 PM EST

Trevi Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -4.57 -4.27 -0.53 -1.33 -1.69 -3.44 -5.5 -11.48
PEG Ratio 0.13 0.06 0.03 0.07 0.55 -0.06 -0.05 n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio 1.61 1.16 1.05 1.60 0.81 4.09 4.79 -7.31
P/FCF Ratio -4.17 -4.4 -0.62 -1.51 -1.9 -3.83 -8.86 -11.38
P/OCF Ratio -4.18 -4.42 -0.62 -1.51 -1.91 -3.87 -8.87 -11.38
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.02 0.09 0.86 0.52 0.01 0.06 0.36 -1.27
Quick Ratio 15.03 9.15 2.98 8.17 11.15 6.50 3.10 0.41
Current Ratio 15.03 9.15 2.98 8.33 11.45 7.02 3.11 0.41
Asset Turnover n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -86.76 -38.34 -27.02 -71.25 n/a -105.79 -2.46 n/a
Return on Equity (ROE) -0.35 -0.27 -1.99 -1.2 -0.48 -1.19 -0.87 0.64
Return on Assets (ROA) -0.33 -0.24 -0.88 -0.7 -0.43 -1 -0.58 -1.32
Return on Capital (ROIC) -0.41 -0.27 -1.26 -0.78 -0.49 -1.03 -0.55 0.72
Dividend Yield n/a n/a n/a n/a 0.05 n/a n/a n/a
Payout Ratio n/a n/a n/a n/a -0.09 n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a n/a